Sage Journals: Discover world-class research

Abstract

Alzheimer's disease (AD) and diabetes rarely occur together, a finding that provides a possible clue as to the development of AD. Abnormal glucose metabolism is not limited to diabetes, but also can include impaired glucose tolerance, insulin resistance, and hyperinsulinemia. AD patients have significantly varying insulin levels after drinking sugared sodas and thus may be classified as insulin resistant. After reviewing the literature on impaired glucose tolerance and insulin production in AD, we present several hypotheses as possible explanations for the relationship between insulin resistance and AD. Finally, we suggest future studies, including studies on use of thiazolidinediones (currently used in the treatment of diabetes) in AD.

Keywords

Alzheimer's disease insulin resistance diabetes blood sugar cognition

Get full access to this article

View all access options for this article.

References

American Diabetes Association. (2000). Diabetes facts and figures [On-line]. Available: http://www.diabetes.org/ada/facts.asp.

Craft

Dagogo-Jack

Wiethop

Murphy

Nevins

Fleischman

Rice

Newcomer

Cryer

(1993). Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: A longitudinal study. Behavioral Neuroscience, 107, 926–940.

Craft

Peskind

Schwartz

Schellenberg

Raskind

Porte

Jr. (1998). Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype. Neurology, 50, 164–168.

Devaskar

(1991). A review of insulin/insulin-like peptide in the central nervous system. In Raizada

LeRoith

(Eds.), Molecular biology and physiology of insulin and insulin-like growth factors (pp. 385–396). New York: Plenum Press.

Doré

Kar

Quiron

(1997). Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity. Neurobiology, 94, 4772–4777.

Fajans

(1996). Definition and classification of diabetes including maturity-onset diabetes of the young. In LeRoith

Taylor

Olefsky

(Eds.), Diabetes mellitus: A fundamental and clinical text (pp. 251–260). Philadelphia: Lippincott-Raven.

Flier

(1993). An overview of insulin resistance. In Moller

D.E.

(Ed.), Insulin resistance (pp. 1–8). New York: John Wiley & Sons.

Hoyer

(1994). Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity. Life Sciences, 55, 1977–1983.

Kurochkin

Goto

(1994). Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Letters, 345, 33–37.

10.

Nielson

Nolan

Berchtold

Sandman

Mulnard

Cotman

(1996). Apolipoprotein-E genotyping of diabetic dementia patients: Is diabetes rare in Alzheimer disease? Journal of the American Geriatrics Society, 44, 897–904.

Evidence of Impaired Glucose Tolerance and Insulin Resistance in Patients With Alzheimer's Disease

Abstract

Keywords

Get full access to this article

References